Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Not yet recruiting · NCT06881888 · Registry updated 2025-10-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Not yet recruiting | Phase 1 | 2025-10-03 | NCT06881888 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Alabama at Birmingham | 467 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | United States | 1 |